FSR 488
Alternative Names: FSR-488Latest Information Update: 31 Jan 2019
At a glance
- Originator Novactyl
- Developer Upsher-Smith
- Class Antivirals
- Mechanism of Action Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Herpes simplex virus infections
Most Recent Events
- 31 May 2017 Upsher-Smith has been acquired by Sawai
- 24 Apr 2007 Discontinued - Preclinical for Herpes simplex virus infections in USA (Topical)
- 14 Nov 2002 Preclinical trials in Herpes simplex virus infections in USA (Topical)